Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Traphaco

Market Cap 3,275B 125M 108M 99.27M 92.92M 174M 11.85B 177M 1.17B 457M 5.77B 468M 458M 19.98B P/E Ratio 2024
15.7x
P/E Ratio 2025 14.3x
Enterprise Value 2,705B 103M 88.99M 82.01M 76.76M 144M 9.79B 146M 968M 378M 4.77B 387M 378M 16.51B EV / Sales 2024
1.16x
EV / Sales 2025 0.96x
Free-Float
55.44%
Yield 2024
5.1%
Yield 2025 -
04-28 Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-23 Traphaco Joint Stock Company Receives Large Enterprise Tax Department Decision on Tax Inspection and Administrative Penalties for Fiscal Years 2023 and 2024 CI
01-29 Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
12-26 Traphaco Joint Stock Company Announces First Cash Dividend Payment in 2025, Payable on January 28, 2026 CI
11-19 Traphaco Joint Stock Company Announces Change in Business Registration Certificate Issued by Hanoi Department of Finance CI
11-10 Traphaco Joint Stock Company Announces Chief Executive Officer Changes, Effective November 10, 2025 CI
11-06 Traphaco Joint Stock Company Announces Resignation of Ms. Nguyen Thi Giang as Member of the Board of Supervisors CI
29/10/25 Traphaco Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
10/09/25 Traphaco Joint Stock Company Announces Dissolution of Branches CI
29/07/25 Traphaco Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
29/04/25 Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
02/02/25 Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
16/12/24 Traphaco Joint Stock Company Approves First Interim Dividend for 2024, Payable on January 24, 2025 CI
1 day-1.13%
1 week-1.25%
Current month-1.25%
1 month-1.25%
3 months+12.22%
6 months+16.86%
Current year+5.33%
1 week 78,100
Extreme 78100
80,800
1 month 78,100
Extreme 78100
81,000
Current year 65,000
Extreme 65000
81,000
1 year 63,000
Extreme 63000
81,000
3 years 63,000
Extreme 63000
95,900
5 years 63,000
Extreme 63000
105,000
10 years 43,100
Extreme 43100
142,000
Manager TitleAgeSince
Chief Executive Officer 61 16/09/2012
Corporate Secretary - 29/03/2018
Comptroller/Controller/Auditor 44 31/12/1993
Director TitleAgeSince
Chairman 70 17/10/2010
Director/Board Member 61 31/12/1993
Director/Board Member 48 29/03/2016
Date Insider Type Main position Quantity % Market Cap.
14/04/25Buy 33,264 0.0802%
04/10/23Sell

Executive/Senior Manager

7,200 0.0174%
Change 5-day change 1-year change 3-year change Capi.($)
-1.13%-1.25%+8.22%-12.90% 125M
-2.41%+0.14%+39.53%+154.43% 1,010B
+1.07%+3.48%+53.75%+50.64% 580B
+1.32%+0.22%+18.35%+65.35% 402B
+0.77%0.00%+19.99%+16.80% 330B
-1.42%-1.44%+45.50%+8.37% 294B
-0.85%-2.86%+22.05%+13.80% 280B
+0.44%+3.48%+24.48%+34.39% 281B
+1.66%+1.20%-44.67%-47.49% 197B
+0.32%+1.61%+19.48%+63.42% 192B
Average -0.37%+0.78%+20.67%+34.68% 356.72B
Weighted average by Cap. -0.80%+1.00%+29.84%+66.16%

Financials

2024 2025
Net sales 2,347B 89.4M 77.22M 71.15M 66.6M 125M 8.5B 127M 840M 328M 4.14B 336M 328M 14.32B 2,657B 101M 87.41M 80.55M 75.4M 141M 9.62B 143M 951M 371M 4.68B 380M 372M 16.21B
Net income 239B 9.1M 7.86M 7.25M 6.78M 12.71M 865M 12.91M 85.55M 33.36M 421M 34.17M 33.44M 1.46B 250B 9.51M 8.21M 7.57M 7.08M 13.28M 904M 13.48M 89.36M 34.84M 440M 35.69M 34.93M 1.52B
Net Debt -540B -20.58M -17.78M -16.38M -15.34M -28.74M -1.96B -29.19M -193M -75.42M -952M -77.25M -75.61M -3.3B -569B -21.69M -18.73M -17.26M -16.16M -30.28M -2.06B -30.75M -204M -79.46M -1B -81.39M -79.66M -3.47B
Logo Traphaco
Traphaco Joint Stock Company is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
Employees
1,546
Date Price Change Volume
12/06/26 79,000.00 -1.13% 1,115
11/06/26 79,900.00 -0.12% 2,734
10/06/26 80,000.00 +0.38% 105
09/06/26 79,700.00 -0.25% 2,738
08/06/26 79,900.00 -0.12% 7,829

Net sales - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!